GeoVax Labs Warrants
GOVXW
GOVXW was delisted on the 26th of September, 2025.
1 hedge funds and large institutions have $15K invested in GeoVax Labs Warrants in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
0% more capital invested
Capital invested by funds: $15K → $15K (+$19)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $15K | – | – | – |
|
2
JP Morgan Chase
New York
| $22 | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$18 | -151 | Closed |
|
GOVXW Hedge Fund Activity: Q2 2023 in Review
1 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q2 2023, worth a combined $15K — up 0.13% from $15K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GOVXW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $18 sold.
- 1 institutional investor held GeoVax Labs Warrants (GOVXW) as of Q2 2023, down from 2 in Q1 2023.
- Funds reported $15K of GeoVax Labs Warrants stock for Q2 2023, up 0.13% quarter-over-quarter.
- 0 funds opened new GeoVax Labs Warrants positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest GeoVax Labs Warrants seller in Q2 2023 was UBS Group, an estimated $18 sold.
Based on aggregated 13F filings for Q2 2023.